Pharma in Brief team

Pharma in Brief team

ID: 1b839947-2619-30fb-68c4

/

Claimed Record

/

Organization: Norton Rose Fulbright

Federal Court finds Minister’s CSP decision unreasonable on patent eligibility for fixed-dose combination drug product

Pharma in Brief · July 28, 2020

PMPRB takes jurisdiction over medicine (again) following Federal Court of Appeal remand

Pharma in Brief · July 7, 2020

Federal Court determines that infringement action under PM(NOC) Regulations is not moot where trial proceeds after patent expiry

Pharma in Brief · June 8, 2020

Federal Court supports virtual trials for intellectual property actions

Pharma in Brief · May 27, 2020

FCA gives guidance for common PM(NOC) trials involving multiple actions

Pharma in Brief · May 25, 2020

Practice Areas

Health Care and Life Sciences

Jurisdictions